Table 4.
Lineage |
Single-drug resistance |
MDR | Total | ||
---|---|---|---|---|---|
Isoniazid | Rifampicin | Other drugs* | |||
Euro-American |
8 (3.4%) |
1 (0.4%) |
2 (0.8%) |
9 (3.8%) |
20 (8.4%) |
Indo-Oceanic (EAI) |
0 |
1 (0.4%) |
0 |
1 (0.4%) |
2 (0.8%) |
East-Asian (Beijing) |
1 (0.4%) |
0 |
0 |
0 |
1 (0.4%) |
Total | 9 (3.8) | 2 (0.8%) | 2 (0.8%) | 10 (4.2%) | 23 (9.7%) |
*Isolates resistant to one first line drug other than isoniazid or rifampicin.